Previous Article | Next Article 
Journal of Virology, April 2005, p. 4793-4805, Vol. 79, No. 8
0022-538X/05/$08.00+0 doi:10.1128/JVI.79.8.4793-4805.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Comprehensive Analysis of Ebola Virus GP1 in Viral Entry
Balaji Manicassamy,
Jizhen Wang,
Haiqing Jiang, and
Lijun Rong*
Department of Microbiology and Immunology, College of Medicine, University of Illinois at Chicago, Chicago, Illinois
Received 27 July 2004/
Accepted 19 November 2004
Ebola virus infection is initiated by interactions between the viral glycoprotein GP1 and its cognate receptor(s), but little is known about the structure and function of GP1 in viral entry, partly due to the concern about safety when working with the live Ebola virus and the difficulty of manipulating the RNA genome of Ebola virus. In this study, we have used a human immunodeficiency virus-based pseudotyped virus as a surrogate system to dissect the role of Ebola virus GP1 in viral entry. Analysis of more than 100 deletion and amino acid substitution mutants of GP1 with respect to protein expression, processing, viral incorporation, and viral entry has allowed us to map the region of GP1 responsible for viral entry to the N-terminal 150 residues. Furthermore, six amino acids in this region have been identified as critical residues for early events in Ebola virus entry, and among these, three are clustered and are implicated as part of a potential receptor-binding pocket. In addition, substitutions of some 30 residues in GP1 are shown to adversely affect GP1 expression, processing, and viral incorporation, suggesting that these residues are involved in the proper folding and/or overall conformation of GP. Sequence comparison of the GP1 proteins suggests that the majority of the critical residues for GP folding and viral entry identified in Ebola virus GP1 are conserved in Marburg virus. These results provide information for elucidating the structural and functional roles of the filoviral glycoproteins and for developing potential therapeutics to block viral entry.
* Corresponding author. Mailing address: Department of Microbiology and Immunology, College of Medicine, University of Illinois at Chicago, E829 MSB, 835 S. Wolcott Ave., Chicago, IL 60612. Phone: (312) 355-0203. Fax: (312) 996-6415. E-mail:
lijun{at}uic.edu.
B.M. and J.W. contributed equally to this work.
Journal of Virology, April 2005, p. 4793-4805, Vol. 79, No. 8
0022-538X/05/$08.00+0 doi:10.1128/JVI.79.8.4793-4805.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Dube, D., Brecher, M. B., Delos, S. E., Rose, S. C., Park, E. W., Schornberg, K. L., Kuhn, J. H., White, J. M.
(2009). The Primed Ebolavirus Glycoprotein (19-Kilodalton GP1,2): Sequence and Residues Critical for Host Cell Binding. J. Virol.
83: 2883-2891
[Abstract]
[Full Text]
-
Daya, S., Berns, K. I.
(2008). Gene Therapy Using Adeno-Associated Virus Vectors. Clin. Microbiol. Rev.
21: 583-593
[Abstract]
[Full Text]
-
Dube, D., Schornberg, K. L., Stantchev, T. S., Bonaparte, M. I., Delos, S. E., Bouton, A. H., Broder, C. C., White, J. M.
(2008). Cell Adhesion Promotes Ebola Virus Envelope Glycoprotein-Mediated Binding and Infection. J. Virol.
82: 7238-7242
[Abstract]
[Full Text]
-
Halfmann, P., Kim, J. H., Ebihara, H., Noda, T., Neumann, G., Feldmann, H., Kawaoka, Y.
(2008). Generation of biologically contained Ebola viruses. Proc. Natl. Acad. Sci. USA
105: 1129-1133
[Abstract]
[Full Text]
-
Kaletsky, R. L., Simmons, G., Bates, P.
(2007). Proteolysis of the Ebola Virus Glycoproteins Enhances Virus Binding and Infectivity. J. Virol.
81: 13378-13384
[Abstract]
[Full Text]
-
Brindley, M. A., Hughes, L., Ruiz, A., McCray, P. B. Jr., Sanchez, A., Sanders, D. A., Maury, W.
(2007). Ebola Virus Glycoprotein 1: Identification of Residues Important for Binding and Postbinding Events. J. Virol.
81: 7702-7709
[Abstract]
[Full Text]
-
Dowling, W., Thompson, E., Badger, C., Mellquist, J. L., Garrison, A. R., Smith, J. M., Paragas, J., Hogan, R. J., Schmaljohn, C.
(2007). Influences of Glycosylation on Antigenicity, Immunogenicity, and Protective Efficacy of Ebola Virus GP DNA Vaccines. J. Virol.
81: 1821-1837
[Abstract]
[Full Text]
-
Shimojima, M., Takada, A., Ebihara, H., Neumann, G., Fujioka, K., Irimura, T., Jones, S., Feldmann, H., Kawaoka, Y.
(2006). Tyro3 family-mediated cell entry of ebola and marburg viruses.. J. Virol.
80: 10109-10116
[Abstract]
[Full Text]
-
Marzi, A., Akhavan, A., Simmons, G., Gramberg, T., Hofmann, H., Bates, P., Lingappa, V. R., Pohlmann, S.
(2006). The Signal Peptide of the Ebolavirus Glycoprotein Influences Interaction with the Cellular Lectins DC-SIGN and DC-SIGNR.. J. Virol.
80: 6305-6317
[Abstract]
[Full Text]
-
Kuhn, J. H., Radoshitzky, S. R., Guth, A. C., Warfield, K. L., Li, W., Vincent, M. J., Towner, J. S., Nichol, S. T., Bavari, S., Choe, H., Aman, M. J., Farzan, M.
(2006). Conserved Receptor-binding Domains of Lake Victoria Marburgvirus and Zaire Ebolavirus Bind a Common Receptor. J. Biol. Chem.
281: 15951-15958
[Abstract]
[Full Text]
-
Schornberg, K., Matsuyama, S., Kabsch, K., Delos, S., Bouton, A., White, J.
(2006). Role of endosomal cathepsins in entry mediated by the ebola virus glycoprotein.. J. Virol.
80: 4174-4178
[Abstract]
[Full Text]
-
Bar, S., Takada, A., Kawaoka, Y., Alizon, M.
(2006). Detection of Cell-Cell Fusion Mediated by Ebola Virus Glycoproteins. J. Virol.
80: 2815-2822
[Abstract]
[Full Text]